Iron chelator and inhibitor of iron-mediated oxidant injury
AssigneeThe Regents of the University of California
InventorsLawrence D. Horwitz, Marcus A. Horwitz, Bradford W. Gibson, Joseph Reeve
Life of this patent
Estimating the term…
Abstract
Exochelins can be used to prevent damage to living tissue from the formation or presence of the (.cndot.OH) radical. In particular, the invention is directed to the administration of exochelins to infarcted myocardium prior to or coincidental with reperfusion to prevent damage to myocardium from iron mediated free radical formation. Also presented is the chemical structure of exochelins and modified exochelins as well as other applications of these materials in the treatment and diagnosis of disease in mammals.
Claims13
A composition for protecting live tissue in a mammal from injury resulting from exposure to the hydroxyl free radical formed following reestablishment of fluid flow to a body organ after restriction of blood flow to that body organ comprising an effective amount of a lipid and water soluble desferriexochelin, said amount being effective to protect said mammal upon the reestablishment of flow of fluid to the tissue.
A composition for preventing injury to living tissue in a mammal from the presence of iron mediated, hydroxyl radical formation comprising an effective amount of at least one compound of the formula:
- ##STR1## wherein R.sub.1 is selected from the group consisting of (CH.sub.2).sub.N COOCH.sub.3 and (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.Y COOCH.sub.3 with N being from 1 to 7 and x+y being from 1 to 5, R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof, and R.sub.3 is selected from the group consisting of H and CH.sub.3 said compound having a molecular weight of from about 663 to 775.
A isolated compound having the formula:
- ##STR2## wherein R.sub.1 is selected from the group consisting of (CH.sub.2).sub.N COOCH.sub.3 and (CH.sub.2).sub.x CH.dbd.CH--(CH.sub.2).sub.y COOCH.sub.3 with N being from 1 to 7 and x+y being from 1 to 5, R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof and R.sub.3 is selected from the group consisting of H and CH.sub.3, said compound having a molecular weight of from about 663 to about 775 daltons.
A composition for delivering an active compound to a mammal to treat a medical condition caused by the formation or presence of hydroxy free radicals, said composition comprising a compound of the formula:
- ##STR3## wherein R.sub.1 is a chemical moiety selected from the group consisting of (CH.sub.2).sub.n CH.sub.3, (CH.sub.2).sub.n COOH, (CH.sub.2).sub.n COOR, (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOH, (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOR, where R is an alkyl group and (CH.sub.2).sub.n CONH.sub.2 where n is from 1 to 7 and x+y is 1 to 5;
- R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof;
- R.sub.3 is a chemical moiety selected from the group consisting of H, CH, and side chains found on .beta.-hydroxy amino acids which are capable of forming cyclic oxazoline structures;
- and
- R.sub.4a, R.sub.4 b, R.sub.5a, R.sub.5b are chemical moleties selected from the group consisting of H, alkyl groups and substituted alkyl groups and x is 0, NH, S or CH.sub.2.
A isolated metal chelate having the formula:
- ##STR4## wherein R.sub.1 is a chemical moiety selected from the group consisting of (CH.sub.2).sub.n CH.sub.3, (CH.sub.2).sub.n COOH, (CH.sub.2).sub.n COOR (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOH, (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOR where R is an alkyl group and (CH.sub.2).sub.n CONH.sub.2 n being from 1 to 7 and x+y is 1 to 5;
- R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof;
- R.sub.3 is a chemical moiety selected from the group consisting of H, CH.sub.3 and side chains found on .beta.-hydroxy amino acids which are capable of forming cyclic oxazoline structures;
- and
- R.sub.4a, R.sub.4b, R.sub.5a, R.sub.5b are chemical moieties selected from the group consisting of H, alkyl groups and substituted alkyl groups;
- and
- M is selected from the group consisting of iron, lead, aluminum, cadmium, nickel, silver, gold, arsenic, magnesium, manganese, zinc, copper, rubidium, niobium, zirconium, tantalum, vanadium, gallium, platinum, chromium, scandium, yttrium, cobalt, titanium, sodium and potassium and x is O, NH, S or CH.sub.2.
A composition for protecting live tissue in a mammal from injury resulting from exposure to the hydroxyl free radical formed following reestablishment of fluid flow to a body organ after restriction of blood flow to that body organ comprising an effective amount of a lipid and water soluble desferriexochelin, said amount being effective to protect said mammal upon the reestablishment of flow of fluid to the tissue, said desferriexochelin being administered in a solution selected from the group consisting of reperfusion solution and cardioplegia solution.
A composition for protecting live tissue in a mammal from injury resulting from exposure to the hydroxyl free radical formed following reestablishment of fluid flow to a body organ after restriction of blood flow to that body organ comprising an effective amount of a compound having the formula:
- ##STR5## wherein R.sub.1 is selected from the group consisting of (CH.sub.2).sub.N COOCH.sub.3 and (CH.sub.2).sub.x CH.dbd.CH--(CH.sub.2).sub.y COOCH.sub.3 with N being from 1 to 7 and x+y being from 1 to 5, R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof and R.sub.3 is selected from the group consisting of H and CH.sub.3, said compound having a molecular weight of from about 663 to about 775, said amount being effective to protect said mammal upon the reestablishment of flow of fluid to the tissue, said compound being administered in a solution selected from the group consisting of reperfusion solution and cardioplegia solution.
A composition for delivering effective amounts of an active compound to a mammal to treat a medical condition caused by the formation or presence of hydroxy free radicals, said composition having the formula:
- ##STR6## wherein R.sub.1 is a chemical moiety selected from the group consisting of (CH.sub.2).sub.n CH.sub.3, (CH.sub.2).sub.n COOH, (CH.sub.2).sub.n COOR (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOH, (CH.sub.2).sub.x CH.dbd.CH(CH.sub.2).sub.y COOR where R is an alkyl group and (CH.sub.2).sub.n CONH.sub.2 where n is from 1 to 7 and x+y is 1 to 5;
- R.sub.2 is a chemical moiety substituted at any of the 4 open sites on the ring, said chemical moiety being selected from the group consisting of alkyl groups, sulfonamides, hydroxyl, halogen, acetyl, carbamyl, amines and NO.sub.2 and combinations thereof;
- R.sub.3 is a chemical moiety selected from the group consisting of H, CH.sub.3 and side chains found on .beta.-hydroxy areinc acids which are capable of forming cyclic oxazoline structures;
- and
- R.sub.4a, R.sub.4b, R.sub.5a, R.sub.5b are chemical moieties selected from the group consisting of H, alkyl groups and substituted alkyl groups said amount being effective to protect said mammal upon the reestablishment of flow of fluid to an organ within the mammal, said composition being administered in a solution selected from the group consisting of reperfusion solution and cardioplegia solution and x is O, NH, S or CH.sub.2.
Dependencies are inferred from the claim text.